Search:
 
BioEnterprise
Recent News

» Clayton Dubilier & Goldman Sachs to Acquire Edgepark Medical for $850 Million
» Great Lakes Pharmaceuticals raises $3.1 Million
» AxioMed Raises $14.5 Million
» Syncro Raises Additional $800,000
» Factory Jobs Return, but Employers Find Skills Shortage
» Two Healthcare Companies Announce Major Expansions
» Ohioans vote for their futures, extend Third Frontier program



Commercialized Products & Services


Syncro Blue Tube
One of the many health care innovations brought to market by client companies.
» View More




Exit Companies



Since 2002, 21 Cleveland-area health care companies have had successful exits.

» View More




Cleveland Medical Mart & Convention Center



The world’s only convention facility created for the health care industry.
» View More
Companies > Clinical
print
Neomed Technologies has developed a novel system called the CADscreen that can greatly improve the physician’s ability to accurately diagnose coronary artery disease. The system's proprietary algorithms generate an index which indicates if there is adequate blood flow in the coronary arteries and aorta.  The test could eliminate many of the 30% of invasive angiographies which are negative, costly and unnecessary.

Funders:
Angels

 
Copyright © 2010 BioEnterprise   | Home | Disclaimer | Sitemap | Contact Us BioEnterprise : 11000 Cedar Avenue, Cleveland, OH 44106 | 216.658.3999